Stroke Patients Benefit from Using AI
Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform.
Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform than patients who received treatment normally. The AI platform used software algorithms on smartphones to confirm patient identity, medication and medication ingestion.
Read the full release here
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
